NCT02492828View on ClinicalTrials.gov

Adherence of Apixaban and Warfarin in Patients With Arterial Fibrillation in Real-world Setting in Sweden

CompletedOBSERVATIONAL
Enrollment

41,000

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Anticoagulation
Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY